• No results found

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

N/A
N/A
Protected

Academic year: 2022

Share "Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia"

Copied!
14
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER